CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
SPIOMET4HEALTH aims to develop a new treatment for Polycystic Ovary Syndrome (PCOS) using a combination of insulin sensitisers and anti-androgens. The project focuses on normalizing ovulation and metabolic health in young women, potentially reducing long-term health risks.
Polycystic Ovary Syndrome (PCOS) is the most prevalent, chronic endocrine-metabolic disorder of adolescents and young women (AYAs), affecting 5-10% of AYAs worldwide.
It is the most frequent cause of anovulatory subfertility.
There is no approved therapy for PCOS.
Standard off-label treatment with oral contraceptives reverts neither the underlying pathophysiology nor the associated co-morbiditiesPilot studies have generated new insights into the pathophysiology of PCOS, and have thus led to the…
FUNDACIO PRIVADA PER A LA RECERCA I LA DOCENCIA SANT JOAN DE DEU
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Spain, Esplugues De Llobregat
Type: Research institute
Activity type: Research Organisations
SME: No
Belgium, Leuven
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, Witten
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
